The majority of viral infections acquired by nonimmunosuppressed individuals are asymptomatic or result in mild clinical manifestations. These individuals are able to mount effective immune responses that either clear the virus from the body or, for viruses that establish latency, maintain the virus in a dormant state. For individuals who are immunocompromised, because of a genetic immunodeficiency or immunosuppressive drug therapy, viral infections may result in life-threatening disease. Such patients present with infections that are severe, persistent, recurrent, or refractory to therapy and are usually caused by viruses of low virulence prevalent in the community.
In this review, we discuss primary immunodeficiencies that predispose individuals to severe viral infections in the presence or absence of an increased susceptibility to severe disease with other pathogens. Primary immunodeficiency disorders can be divided into 2 broad categories: disorders caused by defects in the innate immune system (Toll-like receptors [TLRs] , interferons [IFNs] , natural killer [NK] cells) and those caused by defects in the adaptive immune system (lymphocyte-derived cellular and antibody responses). In the past, susceptibility to severe viral diseases has usually been attributed to deficient lymphocyte responses, especially CD8
1 T-cell responses. However, susceptibility to severe viral diseases is encountered in primary immunodeficiency disorders with deficient innate and/ or adaptive immune responses. Recently, primary immunodeficiencies due to mutations in signaling proteins in the innate immune system have been described [1] . Some of these mutations predispose individuals to severe pathogen-specific diseases; thus, despite the importance of these pathways for the control of multiple pathogens, individual cellular proteins can be important for the control of individual pathogens.
PRIMARY IMMUNODEFICIENCIES WITH A UNIQUE PREDISPOSITION TO A PARTICULAR VIRAL DISEASE
Primary Immunodeficiencies Associated With Severe EpsteinBarr Virus Infection X-linked lymphoproliferative (XLP) syndrome, or Duncan's disease, is characterized by fulminant infectious mononucleosis and/or hemophagocytic lymphohistiocytosis (HLH) that results from failure to control the proliferation of activated T cells and NK cells that arise after Epstein-Barr virus (EBV) infection (Table 1) . If not treated, this frequently progresses to fatal lymphoproliferative disease. Patients with XLP syndrome are usually healthy until they are infected with EBV; however, some patients develop B cell lymphomas, vasculitis, or lymphomatoid granulomatosis in the absence of EBV infection. Two genetic causes of XLP syndrome have been identified. Mutations in signaling lymphocyte activation molecule (SLAM)-associated protein cause XLP-1 and prevent inhibition of signal transduction by SLAM, so that the proliferation of T cells and NK cells continues unchecked with infiltration of organs by these cells [2, 3] . Mutations in X-linked inhibitor of apoptosis cause XLP-2 and predispose to EBV-associated HLH in 90% of affected individuals [4] . Some investigators have suggested that this disease be reclassified as X-linked HLH, because of the high prevalence of HLH, and no patients with lymphoma have been reported [5] . Rituximab has been successful in treating a few patients with XLP-1 and fulminant mononucleosis, but it has not been proved effective in clinical trials [6] . Treatment may include HLH therapy [7] , which includes etoposide and corticosteroids. Hematopoietic stem cell transplantation is curative for XLP-1 [8] .
A mutation in interleukin (IL)-2-inducible T-cell kinase was reported to cause severe EBV-associated lymphoproliferative syndrome in 2 sisters who developed fatal disease with hepatosplenomegaly and hepatic dysfunction; 1 developed B cell lymphoma [9] . Patients with mutations in SLAM-associated protein and IL-2 inducible T-cell kinase have a lack or absence of NK T (NKT) cells, suggesting a probable role for this rare population of lymphocytes in controlling EBV infection.
Chronic active EBV infection is another condition that may result in a severe or fatal lymphoproliferative syndrome. The syndrome is characterized by a progressive EBV-positive lymphoproliferative disease, usually after primary EBV infection, with lymphadenopathy, splenomegaly, liver dysfunction, and often hemophagocytosis. Patients have markedly elevated EBV viral loads in the blood and often develop EBV-positive lymphomas. One patient was described with mutations in both copies of the perforin gene and impaired T-cell killing [10] .
Primary Immunodeficiencies That Predispose to Herpes Simplex Virus 1 Encephalitis
IFNs possess a critical role in defense against viral infections. Production of type I IFNs (a and b) by virus-infected leukocytes, fibroblasts, or epithelial cells is induced by the binding of viral glycoproteins or RNA/DNA to membrane-bound TLRs or cytoplasmic receptors (eg, retinoic acid-inducible gene 1) (Figure 1 ) [11] . These interactions recruit signaling molecules and trigger a cascade of events that produce type I IFNs. In turn, these IFNs bind to receptors and activate other signaling molecules that turn on the expression of IFN-stimulated genes and the antiviral response. TLRs have additional effects on the innate immune response, and they recruit and ultimately lead to activation of antigen-specific B and T cells.
Mutations in 3 proteins in the TLR signaling pathway have been linked to herpes simplex encephalitis (HSE) in children. Two children were reported with autosomal recessive homozygous mutations in UNC-93 homolog B1 (UNC93B1) that caused impaired activity of the protein (Table 1 ) [12] . UNC93B is essential for trafficking of TLR7 and TLR9 from the endoplasmic reticulum (ER) to the endosome and for TLR3, TLR7, TLR8, and TLR9 signaling [13] . The 2 children had recurrent encephalitis that responded to acyclovir but no other symptoms related to herpes simplex virus (HSV) or other viral diseases. The second identified genetic cause of isolated HSE was an heterozygous, autosomal dominant mutation in TLR3 that functioned in a dominant-negative fashion to impair TLR3 activity [14] . The 2 patients presented at ages 5 months and 5 years. One of them had recurrent encephalitis that responded to acyclovir. Interestingly, several family members with the same heterozygous mutation in TLR3 have had no clinical manifestations, indicating that the clinical penetrance of this defect for HSE is incomplete.
An autosomal dominant-negative mutation in tumor necrosis factor receptor-associated factor 3 (TRAF3) was identified in a child who presented at 4 years of age with HSE and recovered [15] . TRAF3 functions downstream of UNC93B and TLR3 in the cytoplasm and leads to production of type I IFNs (Figure 1 ). The evidence suggests that impaired TLR3 signaling via the UNC93B-or TRAF3-dependent pathway is essential for protective immunity to HSV-1 in the central nervous system during the course of primary infection in some children. None of the children with defects in these TLR signaling pathways had other severe viral infections. Most children with a single episode of HSE or recurrent HSE still have no identified genetic cause. However, the fact that mutations in 3 proteins in the IFN signaling pathway predispose to HSE suggests that additional proteins in this pathway may be responsible for other cases of HSE. Prompt treatment with intravenous acyclovir is important, and addition of IFN-a has been proposed.
Primary Immunodeficiencies That Predispose to Severe Human Papillomavirus Infection
Epidermodysplasia verruciformis is a rare autosomal recessive genodermatosis in which patients develop warts on the dorsum of the extremities and pityriasis versicolor-like lesions on the trunk, neck, and face; lesions in sun-exposed areas often become malignant later in life. Lesions are caused by human papillomavirus (HPV) serotypes that are ubiquitous and nonpathogenic in normal populations (Table 1) [16]; they do not regress and are usually refractory to standard therapy, IFN-a, and retinoids. Homozygous mutations in EVER1 and EVER2, adjacent genes on chromosome 17, have been identified in 75% of patients with this condition [17, 18] . The proteins encoded by these genes are membrane proteins in the ER and are predicted to form channels; their function is unknown.
WHIM syndrome, manifested by warts, hypogammaglobulinemia, infections, and myelokathexis (retention of neutrophils in the bone marrow), is a rare autosomal dominant genetic disease caused by mutations in the chemokine receptor gene, CXCR4 (Table 1 ) [19] . This syndrome predisposes individuals to disseminated, chronic, and treatment-refractory warts. In addition, the syndrome is characterized by moderate to severe neutropenia and recurrent sinopulmonary bacterial infections. CXCR4 and its ligand, CXCL12, are important for lymphocyte trafficking, release of neutrophils from the bone marrow, and bone marrow homeostasis. Recent data reveal that patients with WHIM syndrome have a paucity of dendritic cells and an impaired capacity to produce IFN-a in response to viral stimulation [20] .
Primary Immunodeficiencies That Predispose to Severe Enterovirus Infection X-linked agammaglobulinemia (XLA or Bruton's agammaglobulinemia) is caused by failure of B-cell development due to a mutation in the BTK gene that encodes Bruton's tyrosine kinase (Table 1) . Patients usually present between 3 and 18 months of age with poor growth, failure to thrive, and chronic diarrhea. Since patients have agammaglobulinemia or severe hypogammaglobulinemia, they have recurrent bacterial infections, leading to respiratory tract infections, sepsis, osteomyelitis, and meningitis. However, patients with XLA also exhibit an increased susceptibility to infection with enteroviruses (eg, echovirus, poliovirus, coxsackievirus). The most common disease manifestation is chronic meningoencephalitis; hepatitis and dermatomyositis can occur. Patients with XLA can develop poliomyelitis after receiving the live attenuated oral polio vaccine or coming in close contact with a recipient of this vaccine. Patients with autosomal recessive agammaglobulinemia and common variable immunodeficiency are also at increased risk of severe enterovirus infection. Enterovirus infections in these patients are often systemic and chronic and usually fatal. In a study of 201 patients with XLA, the most common cause of death was a chronic enterovirus infection [21] . Other viral infections described in these patients included rotavirus, adenovirus, and hepatitis C virus. Intravenous, and in some cases, intrathecal immunoglobulin (for meningoencephalitis) has been used for treatment. The susceptibility of these patients to severe enterovirus infections reveals the importance of antibody neutralization for controlling these infections.
Primary Immunodeficiency Predisposing to Kaposi Sarcoma
A 2-year-old child born to consanguineous parents developed rapidly progressive, disseminated, fatal Kaposi sarcoma and was found to have a homozygous mutation in stromal interaction molecule 1 (STIM1) [22] . Except for infection with human herpesvirus 8, the child did not have a history of other severe infections. STIM1 is an ER resident transmembrane protein that senses the depletion of ER calcium stores. Two patients with immunodeficiency, opportunistic infections (cytomegalovirus [CMV], varicella zoster virus [VZV]), and autoimmunity were previously reported to have mutations in STIM1 [23] .
PRIMARY IMMUNODEFICIENCIES WITH A PREDISPOSITION TO SEVERE DISEASE ASSOCIATED WITH MULTIPLE VIRUSES AND OTHER MICROBES

Immunodeficiencies Due to Impaired Killing by Cytotoxic T Cells and Natural Killer Cells
Cytotoxic T cells and NK cells kill cells by releasing granules that enter target cells and induce apoptosis ( Figure 2 ). Familial HLH, an autosomal recessive disorder, is caused by a deficiency in 1 of 4 proteins involved in NK and T-cell killing (Table 2 ) [24] . Perforin, munc 13-4, syntaxin 11, and syntaxin-binding protein 2 are important for secretion of cytotoxic granules from NK or cytotoxic T cells or for entry of these granules into virus-infected cells. Familial HLH has frequently been reported to be triggered by EBV, although other viruses (eg, CMV, VZV, HSV, parvovirus B19, adenovirus) and pathogens (eg, bacteria, fungi, parasites) have been implicated. The inability to destroy virusinfected cells causes a persistent, uncontrolled activation of T cells and macrophages with overproduction of inflammatory cytokines and hemophagocytosis. Patients develop liver disease and bone marrow failure which is fatal unless treated. The HLH-2004 protocol, which includes dexamethasone, etoposide, and cyclosporine, can result in remissions; hematopoietic stem cell transplantation is curative [25] .
Three types of NK-cell deficiency syndromes have been described: absolute (absence of NK and NKT cells), classic (absence of NK cells), and functional (impaired NK-cell activity) ( CMV pneumonia, and disseminated HSV [27] . Patients with classic NK-cell deficiency can present with severe HPV infection [28] . Functional NK-cell deficiency is the most common and can present with severe invasive herpesvirus infections. Mutations in CD16 (encoded by the Fc gamma receptor IIIa gene) are the only mutations linked with an NK-cell deficiency to date [29] . CD16 is an Fc receptor expressed on the vast majority of NK cells that facilitates antibody-mediated cellular cytotoxicity and is involved in the lysis of virus-infected cells, independent of antibody binding. NK-cell deficiencies are also part of rare immunodeficiency syndromes, such as Wiskott-Aldrich syndrome [30] .
Immunodeficiencies Resulting From Defects in the Interferon Pathway
Immunodeficiencies involving the IFN pathway include those that affect the production of IFN (eg, nuclear factor [NF]-jB signaling) and those that affect the response of cells to IFN (IFN receptor and signaling molecule mutations) (Figure 1 ). These immunodeficiencies predispose individuals to infection with intracellular pathogens, such as viruses, mycobacteria, and salmonella [31] . X-linked recessive anhidrotic ectodermal dysplasia with immunodeficiency) results from mutations in inhibitor of NF-jb kinase c, also known as NEMO (NF-jb essential modulator). In addition to abnormalities in sweat glands and teeth, mutations in this protein predispose individuals to infections with viruses and bacteria (Table 2 ) [32] . The viral infections in these patients have been caused primarily by herpesviruses (eg, CMV sepsis and colitis; HSV stomatitis, pharyngitis, and encephalitis) ( Table 2 ) [33, 34] .
Homozygous or heterozygous dominant-negative mutations in IFN-c receptors 1 or 2 predispose individuals primarily to disseminated infections with environmental mycobacteria. These patients have increased susceptibility to severe infections with herpesviruses and certain respiratory viruses [35, 36] . Signal transducer and activator of transcription 1 (STAT1) mutations result in failure of type I IFNs to induce expression of IFNinducible genes [37] . Two patients with autosomal recessive STAT1 mutations had disseminated Bacille Calmette-Guérin (BCG) disease and died with disseminated viral infections. IFN-a and IFN-b failed to inhibit virus replication in cells derived from each child. An additional patient with partial STAT1 deficiency with impaired (but not absent) IFN-a and IFN-b signaling had severe CMV and VZV infections [38] .
Tyrosine kinase 2 deficiency, due to a homozygous mutation, was reported in a 22-year-old boy with an original diagnosis of hyperimmunoglobulin E syndrome. Manifestations of this syndrome include recurrent staphylococcal abscesses and respiratory tract infections and markedly elevated serum immunoglobulin (Ig) E concentrations (.2000 IU/mL) [39] . However, the patient also experienced recurrent cutaneous viral infections, BCG lymphadenitis, and disseminated salmonella bacteremia ( Table 2) . Evaluation of immune responses in this patient revealed defects in IL-12 and IFN-a/b signaling (Figure 1) , describing a new primary immunodeficiency.
Viral Infections Associated With the Prototypic Primary Immunodeficiencies
Patients with severe combined immunodeficiency syndromes can present with fatal viral infections (eg, herpesviruses, respiratory viruses, gastrointestinal viruses) that cause mild disease in other children. Vaccination with live attenuated virus vaccines or BCG can result in fatal infection. In addition, infections with bacterial pathogens, fungi, and Pneumocystis can be severe, recurrent, and fatal. These syndromes are characterized by severe defects in antibody and cell-mediated immunity and multiple gene defects [40] . NK cells are absent in 30%-50% of patients, making them more susceptible to severe viral diseases.
Common variable immunodeficiency (CVID) is the most common severe antibody deficiency affecting children and adults [41] . The hallmark of the disease is failure of B-cell differentiation with impaired secretion of immunoglobulins; hence, the most common infections observed in the majority of patients with CVID are recurrent, bacterial sinopulmonary infections. In addition, deficits in T-cell function have been identified in these patients, and CMV viremia and colitis have been reported [42] . Some patients with CVID have developed echovirus meningoencephalitis.
Miscellaneous Syndromes
Patients with dedicator of cytokinesis 8 (DOCK8) deficiency, previously classified as an atypical hyper-IgE syndrome, present with sinopulmonary infections, Staphylococcus aureus skin infections, and persistent, mutilating, recurrent cutaneous viral infections caused by HSV, VZV, molluscum contagiosum virus, or HPV (Table 2; Figure 3) [43, 44] . These viral infections often occur concurrently and frequently are unresponsive to therapy. Although the precise mechanism of DOCK8 in immune function remains to be defined, initial findings suggest a role in T-cell activation and proliferation [44] .
Patients with idiopathic CD4 1 lymphocytopenia are human immunodeficiency virus negative and present with a variety of opportunistic infections, including diffuse, persistent genital and cutaneous HPV infection, persistent and relapsing herpes zoster, EBV lymphoproliferative disease, and progressive multifocal leukoencephalopathy ( Figure 3 ; Table 2 ) [45] .
Patients with the autosomal dominant monocytopenia syndrome present with disseminated, recalcitrant cutaneous and genital papillomavirus infections and with disseminated nontuberculous mycobacterial and fungal infections [46] . Other severe viral infections encountered are caused by HSV, VZV, Recently, mutations in the gene GATA2 were associated with this syndrome, also known as monoMAC [47] .
Evaluation of a Patient With Suspected Primary Immunodeficiency Associated With Severe Viral Infections
The initial evaluation of a patient with suspected primary immunodeficiency is guided by the clinical presentation. The types of infections encountered guide the clinician to evaluate the patient for certain quantitative and functional defects. For example, a patient with viral infections and recurrent sinopulmonary bacterial infections with encapsulated organisms should be evaluated for an antibody deficiency, whereas a patient with viral and disseminated nontuberculous mycobacterial infections should be evaluated for a defect in the IFN pathways. After a thorough history and physical examination focusing on aspects relevant to immunodeficiencies, screening tests should be performed (Figure 4 ). Depending on these results, advanced testing can be performed to further define the identified immune defect [48] . Consultation with an expert in primary immunodeficiency diseases should be sought to establish an accurate diagnosis and help determine the most effective therapy.
CONCLUSIONS
Evaluation of patients with severe viral infections suspected of having a primary genetic immunodeficiency has enhanced our understanding of the important role of specific proteins in the immune system for protection from these infections [49] . The importance of the innate immune system has been demonstrated by the recent identification of mutations in various proteins in the IFN pathway that correlate with an increased susceptibility to viral infections, most notably herpesviruses [31] . The importance of NK cells in defense against viral infections is demonstrated by selective NK-cell deficiency syndromes. Impaired killing by cytotoxic T cells has long been associated with severe viral infections. Further study of the innate and adaptive immune systems will reveal the importance of other proteins in the control of severe viral infections. Thus, viruses continue to teach us about the intricacies of the immune system, and we have much more to learn.
Notes
